By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Invion Limited 

2/120 Bluestone Circuit

Seventeen Mile Rocks    QLD 4073  Australia
Phone: 61-7-3295-0500 Fax: 61-7-3295-0599



Company News
Invion Limited Announces Full Enrollment Of NIH-Sponsored Asthma Trial 11/2/2015 10:20:20 AM
Invion Limited Successfully Completes Phase 2 Study Of INV102 (Nadolol) To Aid Smoking Cessation 10/5/2015 6:10:42 AM
Invion Limited Announces Private Placement To U.S. Institutional Investor 9/1/2015 9:02:25 AM
Invion Limited Completes Clinical Trial Of INV103 (ala-Cpn10) In Lupus Patients 8/17/2015 9:41:57 AM
Invion Limited And Hovione Sign Joint Development And Licensing Agreement For Inhaled Zafirlukast 7/27/2015 1:52:19 PM
Invion Limited Completes Dosing In Key Phase II Clinical Trial Of Oral INV102 (Nadolol) In Smoking Cessation 6/29/2015 9:55:13 AM
Invion Limited Release: INV102 (Oral Nadolol) Data Presented To American Thoracic Society Meeting In Denver, Colorado 5/19/2015 9:38:02 AM
FDA Accepts Invion Limited Proposal To Progress Development Of Inhaled Nadolol To Treat Chronic Respiratory Diseases 3/23/2015 9:49:41 AM
Invion Limited Shows Off Positive Phase 2 Data for Smokers Trying to Quit 1/19/2015 7:25:58 AM
Invion Limited Announces $17.4 Million Investment 11/10/2014 8:33:07 AM